Stocktoria
ANAVEX LIFE SCIENCES CORP. AVXL
ANAVEX LIFE SCIENCES CORP. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $37.6M | $41.8M | $43.7M | $37.9M | $33.0M | $25.2M | $22.3M | $13.3M | $10.7M | $7.3M |
| SG&A expense | $13.8M | $11.0M | $12.0M | — | — | — | — | — | — | — |
| Operating income | -$51.4M | -$52.9M | -$55.8M | -$51.0M | -$42.0M | -$31.1M | — | — | — | — |
| Net income | -$46.4M | -$43.0M | -$47.5M | -$48.0M | -$37.9M | -$26.3M | -$26.3M | -$17.3M | -$13.5M | -$14.7M |
| EPS (diluted) | $-0.54 | $-0.52 | $-0.60 | $-0.62 | $-0.54 | — | — | — | — | $-0.42 |
| Operating cash flow | -$39.0M | -$30.8M | -$27.8M | -$24.2M | -$30.4M | -$21.3M | -$18.5M | -$12.6M | -$9.0M | -$9.2M |
| Cash & equivalents | $102.6M | $132.2M | $151.0M | $149.2M | $152.1M | $29.2M | $22.2M | $22.9M | $27.4M | $9.2M |
| Total assets | $103.8M | $135.6M | $154.4M | $152.7M | $161.6M | $34.5M | $25.3M | $26.2M | $27.8M | $9.5M |
| Total liabilities | $8.9M | $15.3M | $12.5M | $10.2M | $10.8M | $7.3M | $5.0M | — | $3.6M | $3.2M |
| Shareholders' equity | $94.9M | $120.3M | $141.9M | $142.5M | $150.8M | $27.2M | $20.3M | $22.3M | $25.9M | $6.3M |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.